Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Despite promising results in some other lysosomal storage disease, treatment with miglustat does not improve behavioral problems in patients with type III mucopolysaccharidosis,…
NEW YORK (Reuters Health) – The average of five or six blood pressure measurements are needed in order to classify patients with reasonable certainty as having blood pressure…
NEW YORK (Reuters Health) – Antenatal indomethacin given to prevent preterm labor is associated with a significantly increased risk of necrotizing enterocolitis in premature infants, investigators report in…
NEW YORK (Reuters Health) – Some patients with metastatic clear-cell renal cancer appear to fare relatively well when treated with sunitinib before undergoing planned nephrectomy — even though…
NEW YORK (Reuters Health) – Men with benign prostatic hyperplasia experience a similar reduction in urinary symptoms whether they’re treated with dutasteride or finasteride, according to the results…
NEW YORK (Reuters Health) – Among women treated for heavy menstrual bleeding, those undergoing endometrial ablation are less likely than those having a hysterectomy to need subsequent surgery…
NEW YORK (Reuters Health) – Using intra-arterial chemotherapy to treat retinoblastoma can produce a “dramatic response,” but also comes with the risk of both mild and severe side…
NEW YORK (Reuters Health) – Tc-99m dimercaptosuccinic acid (DMSA) renal scanning is not an accurate test for identifying children with dilating vesicoureteral reflux (VUR), suggest results of a…
NEW YORK (Reuters Health) – In pregnancy, antiepileptic drug (AED) polytherapy that includes valproate poses a higher risk of fetal malformations than therapy without this drug, according to…
NEW YORK (Reuters Health) – The benefit of cardiac resynchronization therapy (CRT) in patients with heart failure depends on their QRS interval; CRT does not reduce adverse clinical…
